arrow
É

Élisabeth Quoix

strasbourg
H指数:58
被引数:1.4万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Efficacy of neratinib-based therapy in ERBB2-mutant lung adenocarcinomas: findings from 2 international phase 2 studies

奈拉替尼为基础疗法在ERBB2突变型肺腺癌中的疗效:2项国际II期研究的结果

2025-10-010
PRE
Pattern of clinical activity of anticancer vaccine OSE2101 in HLA-A2+non-small cell lung cancer (NSCLC) patients after failure to immune checkpoint inhibitors (IO) in phase III Atalante-1 randomized trial
2022-09-010
OAAI
Activity of OSE-2101 in HLA-A2+non-small cell lung cancer (NSCLC) patients after failure to immune checkpoint inhibitors (IO): Final results of phase III Atalante-1 randomised trial
2021-09-017
OAAI
Switch maintenance chemotherapy versus observation after carboplatin and weekly paclitaxel doublet chemotherapy in elderly patients with advanced non-small cell lung cancer: IFCT-1201 MODEL trial

老年晚期非小细胞肺癌患者卡铂和每周紫杉醇双重化疗后切换维持化疗与观察: IFCT-1201模型试验

2020-10-014
PREAI
Health-related quality of life in elderly patients with advanced non-small cell lung cancer comparing carboplatin and weekly paclitaxel doublet chemotherapy with monotherapy
2016-06-2312
OAAI
Prognostic value of health-related quality of life for overall survival in elderly non-small-cell lung cancer patients

健康相关生活质量对老年非小细胞肺癌患者总生存期的预测价值

2016-01-0139
PREAI
Impact of EGFR mutations and KRAS amino acid substitution on the response to radiotherapy for brain metastasis of non-small-cell lung cancer

EGFR突变和KRAS氨基酸替代对非小细胞肺癌脑转移放疗疗效的影响

2015-11-3021
PREAI